Company
Carl Dambkowski
Board Member
Oruka Therapeutics, Inc. (ORKA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Carl Dambkowski
Carl Dambkowski is recorded as Board Member at Oruka Therapeutics, Inc. (ORKA). Oruka Therapeutics, Inc. reported in an 8-K filed September 5, 2024 that Carl Dambkowski was appointed director (Class I), effective August 29, 2024.
“On August 29, 2024, the Board increased its size from five to six members and appointed the following six individuals to the Board: Lawrence Klein, Kristine Ball, Carl Dambkowski, Peter Harwin, Samarth Kulkarni and Cameron Turtle.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Organization not stated
Proxy statement
CurrentStart not stated–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Oruka Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Lawrence Klein CEO, Board Member
- Thomas A. Keuer CEO
- Samarth Kulkarni Chairman, Board Member
- C. Jeff Dekker CFO
- C. Jeffrey Dekker CFO
- Laura Sandler COO
- Former Secretary General Counsel
- Paul Quinlan General Counsel
- Anders Hove Board Member
- Cameron Turtle Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.